Invech Holdings Files Q1 2025 10-Q

Ticker: IVHI · Form: 10-Q · Filed: May 12, 2025 · CIK: 1009919

Invech Holdings, Inc. 10-Q Filing Summary
FieldDetail
CompanyInvech Holdings, Inc. (IVHI)
Form Type10-Q
Filed DateMay 12, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, quarterly-report, financials

Related Tickers: IVHI

TL;DR

Invech Holdings (IVHI) filed its Q1 2025 10-Q. Financials look stable.

AI Summary

Invech Holdings, Inc. filed its quarterly report for the period ending March 31, 2025. The company, formerly known as Amersin Life Sciences CORP, HUBEI PHARMACEUTICAL GROUP LTD, and PAN ASIA COMMUNICATIONS CORP, is incorporated in Nevada and operates in management consulting services. Key financial data points such as preferred stock, common stock, additional paid-in capital, and retained earnings as of March 31, 2025, and December 31, 2024, are detailed in the filing.

Why It Matters

This filing provides a snapshot of Invech Holdings' financial position at the end of the first quarter of 2025, offering insights into its capital structure and retained earnings.

Risk Assessment

Risk Level: low — The filing is a routine quarterly report and does not indicate any immediate or significant risks.

Key Numbers

  • N/A — Preferred Stock (As of March 31, 2025, and December 31, 2024)
  • N/A — Common Stock (As of March 31, 2025, and December 31, 2024)
  • N/A — Additional Paid-In Capital (As of March 31, 2025, and December 31, 2024)
  • N/A — Retained Earnings (As of March 31, 2025, and December 31, 2024)

Key Players & Entities

  • Invech Holdings, Inc. (company) — Filer of the 10-Q
  • Amersin Life Sciences CORP (company) — Former name of Invech Holdings
  • HUBEI PHARMACEUTICAL GROUP LTD (company) — Former name of Invech Holdings
  • PAN ASIA COMMUNICATIONS CORP (company) — Former name of Invech Holdings
  • 20250331 (date) — End of reporting period
  • 2024-12-31 (date) — Prior year-end date for comparison

FAQ

What is the primary business of Invech Holdings, Inc.?

Invech Holdings, Inc. operates in the Services-Management Consulting Services sector, with SIC code 8742.

When is the period covered by this 10-Q filing?

This 10-Q filing covers the period ending March 31, 2025.

What were some of the previous names of Invech Holdings, Inc.?

Invech Holdings, Inc. was formerly known as Amersin Life Sciences CORP, HUBEI PHARMACEUTICAL GROUP LTD, and PAN ASIA COMMUNICATIONS CORP.

What is the state of incorporation for Invech Holdings, Inc.?

Invech Holdings, Inc. is incorporated in Nevada (NV).

What are the dates for which financial data points like Preferred Stock and Common Stock are provided?

Financial data points such as Preferred Stock, Series A Preferred Stock, Common Stock, Additional Paid-In Capital, and Retained Earnings are provided for March 31, 2025, December 31, 2024, and December 31, 2023.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 12, 2025 regarding Invech Holdings, Inc. (IVHI).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.